by AmerisourceBergen Drug Corp · 100 CAPSULE, LIQUID FILLED in 1 BOTTLE
This is a package of 100 capsules of Good Neighbor Pharmacy Stool Softener Docusate Calcium 240 mg Capsule, Liquid Filled from AmerisourceBergen Drug Corp, no longer marketed (first marketed May 2021), no longer in the FDA NDC Directory; retail pharmacies pay about $0.0509 per capsule (NADAC). It is this product's only package size.
NDC 46122-0688-78
🏷️ FDA NDC (as labeled)46122-688-78billing pads the product segment with a zero
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 2, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy
NDC database record
One package, one record: these facts belong to NDC 46122-688-78 alone.
Record
FDA NDC Directory package listing · Human OTC drug
Code segments
46122 labeler · 688 product · 78 package
Package marketed since
May 13, 2021
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 4612268878 9
Medicaid fills, this package
11 prescriptions in the last four reported quarters
FDA record last changed
Jul 2, 2026
⚠️
Excluded from the active FDA NDC Directory.
The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Jul 2025. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory.
Search the FDA NDC Directory ↗
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA listing statusDiscontinued by firm (certified through Jul 2025)
Marketing start2021-05-13
RouteORAL
Dosage formCAPSULE, LIQUID FILLED
SubstanceDOCUSATE CALCIUM
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
GPI-1446500010100105
GPI classGNP Stool Softener
GCN Seq No003005
GCN09061
HICL code001324
Ingredient (HICL)Docusate Calcium
HIC1 codeD
Therapeutic class — broad (HIC1)Biliary System/Gastro-Intestinal System
HIC2 codeD6
Therapeutic class — intermediate (HIC2)Drugs Acting Principally On The Colon
HIC3 codeD6S
Therapeutic class — specific (HIC3)Laxatives And Cathartics
AHFS code56:12.00.00
AHFS classCathartics And Laxatives
FDB label nameGNP STOOL SOFTENER 240 MG SFGL
FDB brand nameStool Softener
Legend statusO — Over-the-counter (OTC) drug or device
Quick answers
GSN (GCN sequence number):003005
GCN:09061
GPI-14 (Medi-Span):46500010100105
HICL (First Databank):001324
AHFS class code:56:12.00.00
RxCUI (RxNorm):1245376
Why two NDCs?
The FDA registers this code as 46122-688-78 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 46122-0688-78. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
This medicine belongs to the Softeners, emollients class.
Drug family (ATC)Softeners, emollients
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
Label name GNP STOOL SOFTENER 240 MG SFGLIngredient Docusate Calcium
🧪 What is this product?
Good Neighbor Pharmacy Stool Softener is an oral capsule containing docusate calcium, an over-the-counter product marketed under FDA's monograph rules for its category. Docusate calcium is typically used to soften stool and ease bowel movements by increasing water retention in the intestines. This product is commonly used by people seeking relief from occasional constipation or difficulty with bowel regularity.
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
Price system
Per ea
Per package
Retail pharmacies payNADAC · weekly
$0.051
$5.09 / 100 capsules
Medicaid paysCMS SDUD · 12 mo
$0.2293
$22.93 / 100 capsules
Medicare drug plans payPart D · quarterly
No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
▼ Down 17% over the last 12 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
Inactive ingredients, also called excipients, are components of the drug product
other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors,
or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerAmerisourceBergen Drug Corp
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code46122
First marketedMay 2021
Product typeHuman Otc Drug
Portfolio13 products on file
More NDCs from AmerisourceBergen Drug Corp labeler code 46122
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
Uses For the relief of occasional constipation. This product generally produces a bowel movement within 12 to 72 hours.
⏱️Dosage and Administration54 words▾
Directions Adults and Children over 12 years of age Take orally 1 softgel daily for 2 to 3 days or until bowl movements are normal, or as directed by a doctor. Children under 12 years of age Do not use this product for children under 12 years of age, unless directed by a doctor.
⚠️Warnings34 words▾
Warnings: Do not use If you are currently taking mineral oil, unless directed by a doctor. When abdominal pain, nausea or vomiting are present. For longer than one week unless directed by a doctor.
🧪Active Ingredient6 words▾
Active ingredient Docusate Calcium 240 mg
🧪Inactive Ingredients12 words▾
Inactive Ingredients FD&C Blue #1, FD&C Red #40, Gelatin, Glycerin, Sorbitol Special.
🎯Purpose3 words▾
Purpose Stool Softener
📄Ask a Doctor Before Use If25 words▾
Ask a Doctor Before Use ■ stomach pain ■ nausea ■ vomiting ■ noticed a sudden change in bowel habits that lasts over 2 weeks
📄Stop Use and Ask a Doctor If20 words▾
Stop Use and Ask a Doctor If You have rectal bleeding. You fail to have a bowel movement after use.
🤰If Pregnant or Breast-Feeding11 words▾
If Pregnant or Breast Feeding Ask a healthcare professional before use.
📄Keep Out of Reach of Children23 words▾
Keep Out of Reach of Children. In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
📄Other Information23 words▾
Other Information Store at room temperature between 15ºC to 25ºC (59ºF to 77ºF). Do not use if either seal is broken or missing.
📄Questions or Comments24 words▾
Questions or Comments Distributed by AmerisourceBergen 1300 Morris Drive, Chesterbrook, PA 19087 Questions or Concerns? www.mygnp.com Questions? 800-321-7178 MADE IN ROMANIA REV. 2/21 DOCC110GN
📄Package Label / Principal Display Panel5 words▾
Package/Label Principal Display Panel 1
No label section mentions that — try another word, or open the full label on DailyMed below.
Glossary — plain-language definitions of medical terms used in this label:
abdominal pain: Pain, cramping, or discomfort felt anywhere in the belly area.
Active ingredient: The part of a medicine that produces its intended effect on the body.
constipation: Having bowel movements less often than usual, or passing stools that are hard, dry, and difficult to move.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
11
Units reimbursed last 4 qtrs
60
Gross reimbursed last 4 qtrs
$13.76
Avg / prescription
$1.25
Avg / unit
$0.2293
Latest quarter Q1 2026
0Rx
Medicaid pays / ea
$0.2293
gross reimbursed
vs
NADAC / ea
$0.0509
acquisition cost
=
Spread
+$0.1784
+350% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
100% FFS
Fee-for-service · 11 Rx Managed care · 0 Rx
State Medicaid map
Units reimbursed · per 100k residents
1.31.3
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
1Kentucky1.3 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
About this NDC listing & data coverage
Over-the-counter (OTC) productNo longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes)
✓ Available
Labeler
✓ Available
Product & package description
✓ Available
Marketing category & status
✓ Available
Active ingredient / dosage form / route
✓ Available
FDA label (SPL via DailyMed)
✓ Available
Package photos
— Not published for this NDCNo photo available yet for this listing.
Inactive ingredients (structured)
— Not published for this NDCThe labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS)
✓ Available
Orange Book / therapeutic-equivalence data
— Not published for this NDCApplies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk
— Not published for this NDCMost self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD)
✓ Available
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Who lists this product with the FDA?
AmerisourceBergen Drug Corp is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.